Literature DB >> 25415089

Blindness caused by cosmetic filler injection: a review of cause and therapy.

Jean D A Carruthers1, Steve Fagien, Rod J Rohrich, Susan Weinkle, Alastair Carruthers.   

Abstract

Vascular occlusion causing blindness is a rare yet greatly feared complication of the use of facial aesthetic fillers. The authors performed a review of the aesthetic literature to ascertain the reported cases of blindness and the literature reporting variations in the vascular anatomy of the human face. The authors suggest a small but potentially helpful addition to the accepted management of the acute case. Cases of blindness, mostly irreversible, from aesthetic filler injections have been reported from Asia, Europe, and North America. Autologous fat appears to be the most frequent filler causing blindness. Some cases of partial visual recovery have been reported with hyaluronic acid and calcium hydroxylapatite fillers. The sudden profusion of new medical and nonmedical aesthetic filler injectors raises a new cause for alarm about patient safety. The published reports in the medical literature are made by experienced aesthetic surgeons and thus the actual incidence may be even higher. Also, newer injectors may not be aware of the variations in the pattern of facial vascular arborization. The authors present a summary of the relevant literature to date and a suggested helpful addition to the protocols for urgent management.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25415089     DOI: 10.1097/PRS.0000000000000754

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  35 in total

1.  Visual Loss after Platelet-rich Plasma Injection into the Face.

Authors:  Emely Z Karam; Alexander Gan; Rafael Muci Mendoza; Edwing Martinez; Evlyn Perez
Journal:  Neuroophthalmology       Date:  2020-03-26

Review 2.  [Responsible application of hyaluronic acid fillers in aesthetic medicine : Prevention, diagnosis and therapy of adverse events and complications].

Authors:  Wolfgang G Philipp-Dormston
Journal:  Hautarzt       Date:  2021-04-20       Impact factor: 0.751

3.  [Hyaluronic acid fillers in dermatology].

Authors:  Wolfgang G Philipp-Dormston
Journal:  Hautarzt       Date:  2018-06       Impact factor: 0.751

4.  This month's guideline: The Use of Hyaluronidase in Aesthetic Practice (v2.4).

Authors:  Martyn King; Cormac Convery; Emma Davies
Journal:  J Clin Aesthet Dermatol       Date:  2018-06-01

5.  Transparency and Dermatologic Device Approval by the US Food and Drug Administration.

Authors:  Harib H Ezaldein; Jeffrey F Scott; Emily S Yin; Alessandra Ventura; Nicholaas P DeRuyter; David J Leffell
Journal:  JAMA Dermatol       Date:  2018-03-01       Impact factor: 10.282

6.  Injectable Shape-Memorizing Three-Dimensional Hyaluronic Acid Cryogels for Skin Sculpting and Soft Tissue Reconstruction.

Authors:  Liying Cheng; Kai Ji; Ting-Yu Shih; Anthony Haddad; Giorgio Giatsidis; David J Mooney; Dennis P Orgill; Christoph S Nabzdyk
Journal:  Tissue Eng Part A       Date:  2017-01-02       Impact factor: 3.845

7.  [Sudden loss of vision after cosmetic face treatment].

Authors:  F N Auerbach; R Khoramnia; G U Auffarth; J A Carmona Hernandez; T Tandogan; D Kaiser; S Hähnel; S Sel
Journal:  Ophthalmologe       Date:  2018-07       Impact factor: 1.059

8.  Hyperbaric Oxygen Treatment of Keratitis Following Facial Hyaluronic Acid Injection.

Authors:  Nancy Worley; Mary Lupo; Kate Holcomb; Ginny Kullman; Ebrahim Elahi; Jasmine Elison
Journal:  Ochsner J       Date:  2020

9.  An Efficacy and Safety Study of Intra-arterial Recanalization of Occluded Ophthalmic Arteries in Patients with Monocular Blindness Caused by Injection of Hyaluronic Acid in Facial Tissues.

Authors:  Jianfeng Wang; Haiyang Shen; Tao Liu; Qian Li; Zhaoyang Lyu; Youtao Yu
Journal:  Aesthetic Plast Surg       Date:  2021-03-26       Impact factor: 2.326

10.  Prevention and management of vision loss relating to facial filler injections.

Authors:  Kwok Thye David Loh; Jun Jin Chua; Hung Ming Lee; Joyce Teng-Ee Lim; Gerard Chuah; Benjamin Yim; Boon Kwang Puah
Journal:  Singapore Med J       Date:  2016-08       Impact factor: 1.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.